By Denny Jacob
GE HealthCare trimmed its estimates for the year after assuming the impact of tariffs on its outlook.
The maker of magnetic-resonance imaging scanners and other health-care machines now expects adjusted earnings per-share to be in the range of $3.90 to $4.10. It previously guided for adjusted earnings between $4.61 a share and $4.75 a share.
Free cash flow is now expected to be at least $1.2 billion, down from prior guidance calling for at least $1.75 billion.
Chief Executive Peter Arduini said the company is actively driving mitigation actions in regards to the current global trade environment.
The Chicago company logged net income of $564 million, or $1.23 a share, up from $374 million, or 81 cents a share, in the prior-year period.
Stripping out certain one-time items, earnings came in at $1.01 a share. Analysts polled by FactSet expected 91 cents a share.
Revenue rose to $4.78 billion from $4.65 billion. Analysts polled by FactSet expected $4.66 billion.
GE HealthCare said revenue growth was broad-based with growth in each segment, with overall strength in the U.S.
GE HealthCare also announced its board authorized the repurchase of up to $1 billion of the company's common stock.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 30, 2025 07:12 ET (11:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。